/Hologic%2C%20Inc_%20%20magnified%20-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
Marlborough, Massachusetts-based Hologic, Inc. (HOLX) develops, manufactures, and supplies diagnostic products, imaging systems, and surgical products for women's health, helping in the early detection and treatment of diseases worldwide. With a market cap of $15.1 billion, Hologic operates through Diagnostics, Breast Health, GYN Surgical, and Skeletal Health segments.
The company has significantly underperformed the broader market over the past year. HOLX stock has declined 15.4% over the past 52 weeks and 4.3% on a YTD basis, lagging behind the S&P 500 Index’s ($SPX) 19% surge over the past year and 10% returns in 2025.